Uniqure NV (QURE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $17.11
• Market Cap: $1.55B
• EPS: $-4.55
• 52-Week High: $71.50
• 52-Week Low: $7.76

Market Sentiment

Uniqure NV currently has a Bearish sentiment score of -0.41.

About Uniqure NV

uniQure NV is a pioneering gene therapy company focused on developing innovative treatments for patients with genetic disorders and other severe diseases. Headquartered in Amsterdam, the Netherlands, uniQure leverages its proprietary AAV-based gene therapy platform to address unmet medical needs, aiming to provide long-lasting solutions for conditions such as hemophilia and neurodegenerative diseases. With a robust pipeline of product candidates and a commitment to transforming patient care t...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Uniqure NV and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does QURE pay dividends?

Uniqure NV (QURE) does not currently pay a regular dividend.

What is QURE's market cap?

Uniqure NV (QURE) has a market capitalization of $1.55B with a current stock price of $17.11.